Cargando…
Therapeutic potential of Lianhua Qingke in airway mucus hypersecretion of acute exacerbation of chronic obstructive pulmonary disease
BACKGROUND: Lianhua Qingke (LHQK) is an effective traditional Chinese medicine used for treating acute tracheobronchitis. In this study, we evaluated the effectiveness of LHQK in managing airway mucus hypersecretion in the acute exacerbation of chronic obstructive pulmonary disease (AECOPD). METHODS...
Autores principales: | Hao, Yuanjie, Wang, Tongxing, Hou, Yunlong, Wang, Xiaoqi, Yin, Yujie, Liu, Yi, Han, Ningxin, Ma, Yan, Li, Zhen, Wei, Yaru, Feng, Wei, Jia, Zhenhua, Qi, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623880/ https://www.ncbi.nlm.nih.gov/pubmed/37924136 http://dx.doi.org/10.1186/s13020-023-00851-4 |
Ejemplares similares
-
Exacerbations of chronic obstructive pulmonary disease and chronic mucus hypersecretion
por: Tesfaigzi, Yohannes, et al.
Publicado: (2006) -
Clinical significance of airway mucus hypersecretion in chronic obstructive pulmonary disease
por: Tian, Pan-wen, et al.
Publicado: (2015) -
Lianhua Qingke ameliorates lipopolysaccharide‐induced lung injury by inhibiting neutrophil extracellular traps formation and pyroptosis
por: Peng, Wenjun, et al.
Publicado: (2023) -
Association of the CFTR gene with asthma and airway mucus hypersecretion
por: Crespo-Lessmann, Astrid, et al.
Publicado: (2021) -
Discovery of a drug to treat airway mucus hypersecretion
por: Dickey, Burton F., et al.
Publicado: (2022)